Evidence map›Paper›PMID 27530282›Full record

ArticleProbiotics and antimicrobial proteins2016

The Effect of a Yeast Probiotic on Acute Diarrhea in Children.

Mohammad Reza Sharif, Hamed Haddad Kashani, Abbas Taghavi Ardakani, Davood Kheirkhah, Fatemeh Tabatabaei, Alireza Sharif

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-ResistantFrontiers in cellular and infection microbiology · 2017
    Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mohammad Reza SharifInfectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Hamed Haddad KashaniAnatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Abbas Taghavi ArdakaniInfectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Davood KheirkhahInfectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Fatemeh TabatabaeiEndocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza SharifInfectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran. Asharif@gmail.com.
Kashan University of Medical Sciences · IRIsfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A probiotic is a living micro-organism administered to promote the health of the host by treating or preventing infections owing to strains of pathogens. Saccharomyces boulardii is a nonpathogen yeast that has a direct inhibitory effect on the growth of many pathogens, an anti-secretory effect and a trophic effect on enterocytes. The aim of this study was to determine the effect of S. boulardii on diarrhea in children. The children from 6 months to 6 years of age with acute watery diarrhea admitted in pediatric clinic in Kashan in 2012 were included in this trial. Exclusion criteria were high fever (T > 38.5 °C), severe dehydration, bloody diarrhea, severe malnutrition, using of antibiotics, anti-diarrheal or antifungal drugs and children with more than one complain. Two hundred patients were assigned into two groups: A total of 100 patients were treated with S. boulardii in addition to ORS (case group) and 100 patients were given placebo in addition to ORS (control group). The duration of diarrhea and frequency of stools were recorded by asking the mothers of the children every day. The results showed that the defecation frequency after second day of treatment in the case group was significantly less than the control group (P = 0.001) and the mean numbers of days of diarrhea was significantly lower in the case group (P = 0.001). The result of this study confirms that S. boulardii reduces the frequency of stool and duration of illness in children.

Indexed as

ProbioticsSaccharomyces boulardiiChildChild, PreschoolDiarrheaHumansInfantTreatment OutcomeAcute diarrheaChildrenProbioticSaccharomyces boulardiiYeast

Identifiers

PMID27530282
OpenAlexW2518440577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.